Recombinant multi-species EML4/EMAP-4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EML4/EMAP-4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the echinoderm microtubule associated protein-like family. The encoded WD-repeat protein may be involved in microtubule formation. Abnormal fusion of parts of this gene with portions of the anaplastic lymphoma receptor tyrosine kinase gene, which generates EML4-ALK fusion transcripts, is one of the primary mutations associated with non-small cell lung cancer. Alternative splicing of this gene results in two transcript variants. [provided by RefSeq, Jan 2015]
The Alternative Names of target: 4930443C24Rik,C2orf2,ELP120,EMAP-4,EMAPL4,EML4,Echinoderm microtubule-associated protein-like 4,Eml4,ROPP120,Restrictedly overexpressed proliferation-associated protein,Ropp 120

Target products collectionGo to EML4/EMAP-4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T20296-Ag-1/ GM-Tg-hg-T20296-Ag-2 Human EML4/EMAP-4 protein Human
GM-Tg-rg-T20296-Ag-1/ GM-Tg-rg-T20296-Ag-2 Rat EML4/EMAP-4 protein Rat
GM-Tg-mg-T20296-Ag-1/ GM-Tg-mg-T20296-Ag-2 Mouse EML4/EMAP-4 protein Mouse
GM-Tg-cynog-T20296-Ag-1/ GM-Tg-cynog-T20296-Ag-2 Cynomolgus/Rhesus macaque EML4/EMAP-4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T20296-Ag-1/ GM-Tg-felg-T20296-Ag-2 Feline EML4/EMAP-4 protein Feline
GM-Tg-cang-T20296-Ag-1/ GM-Tg-cang-T20296-Ag-2 Canine EML4/EMAP-4 protein Canine
GM-Tg-bovg-T20296-Ag-1/ GM-Tg-bovg-T20296-Ag-2 Bovine EML4/EMAP-4 protein Bovine
GM-Tg-equg-T20296-Ag-1/ GM-Tg-equg-T20296-Ag-2 Equine EML4/EMAP-4 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T20296-Ag-1/ GM-Tg-hg-T20296-Ag-2; GM-Tg-rg-T20296-Ag-1/ GM-Tg-rg-T20296-Ag-2;
GM-Tg-mg-T20296-Ag-1/ GM-Tg-mg-T20296-Ag-2; GM-Tg-cynog-T20296-Ag-1/ GM-Tg-cynog-T20296-Ag-2;
GM-Tg-felg-T20296-Ag-1/ GM-Tg-felg-T20296-Ag-2; GM-Tg-cang-T20296-Ag-1/ GM-Tg-cang-T20296-Ag-2;
GM-Tg-bovg-T20296-Ag-1/ GM-Tg-bovg-T20296-Ag-2; GM-Tg-equg-T20296-Ag-1/ GM-Tg-equg-T20296-Ag-2
Products Name EML4/EMAP-4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name EML4/EMAP-4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EML4/EMAP-4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.